Gen AI is accelerating change in healthcare and life sciences. In healthcare, a recent McKinsey survey found that 85 percent of respondents—leaders from payers, health systems, and healthcare services and technology (HST) groups—are exploring or already using the technology. As for life sciences, gen AI alone could unlock $60 billion to $110 billion in value, according to Delphine Zurkiya, Joachim Bleys, and coauthors. As advancements continue across both sectors, explore some of McKinsey’s latest insights to stay ahead.
Generative AI in healthcare: Current trends and future outlook
Simplification for success: Rewiring the biopharma operating model
Gen AI: A game changer for biopharma operations
Faster, smarter trials: Modernizing biopharma’s R&D IT applications
Rewiring healthcare payers: A guide to digital and AI transformation
MORE FROM MCKINSEY
Scientific AI: Unlocking the next frontier of R&D productivity